Janssen and GSK provide keynote addresses at Controlled Release Delivery 2017

Posted: 20 February 2017 | | No comments yet

Returning to Central London for the 14th year, SMi’s Controlled Release Delivery conference will take place on the 3rd & 4th of April 2017…


The two day conference will provide attendees with 5+ hours of networking time, an exclusive post-conference workshop and 16 thought provoking presentations covering the topics of; innovations in drug delivery; nanoparticles, nanomedicine & QbD, CNS drug delivery and therapeutic applications.

Hear from Merck, Novartis, Janssen, Actelion, GSK, Boehringer Ingelheim and many more as they evaluate: generic drug development, biopharmaceutical approaches, oral bioavailability and parenteral drug delivery.

Keynote addresses for Controlled Release Delivery 2017:

René Holm, Head and Scientific Director, Liquids & Parenterals, from Janssen will be presenting on ‘Lipid suspensions – how, when and with what?’ René will discuss:

  • What is a lipid based suspension and how could it look from a commercialisation perspective?
  • When can lipid based suspensions be used to improve the oral bioavailability?
  • How large a proportion of the compound needs to be solubilised in the lipid phase?
  • What excipients to use for lipid based formulation?

Mark Wilson, Director, Technology Licensing, PTS from GlaxoSmithKline will be speaking on ‘The development and commercialisation of drug delivery systems: Challenges and opportunities’, where he will provide attendees with information on the following:

  • GSK’s experiences in developing technologies
  • The collaborative “open innovation” approach
  • Commercialisation challenges – finding the breakthrough application
  • Examples of successful development and exploitation projects
  • GSK’s approach to working with other organisations

A full speaker line-up and detailed conference agenda is available to download online at . For those looking to attend, there is currently a £100 discount available which expires on 28th February 2017.

Controlled Release Delivery

Strengthening innovation and overcoming the challenging regulatory landscape
3rd & 4th April 2017
London, UK
Sponsored by: Avanti Polar Lipids, Buchi, Data Detection Technologies, Precision NanoSystems and Sirius Analytical    

Contact Information:

For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: [email protected]

To register for the conference, visit or contact Ameenah Begum for group bookings on Tel: +44 (0)20 7827 6166 / Email: [email protected]

To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: [email protected] 

Related organisations

Related people